CoChat

H3K27me3 conditions chemotolerance in triple-negative breast cancer

Open access
Marsolier, Justine, Prompsy, Pacôme, Durand, Adeline, Lyne, Anne-Marie, Landragin, Camille, Trouchet, Amandine, Bento, Sabrina Tenreira, Eisele, Almut, Foulon, Sophie, Baudre, Léa, Grosselin, Kevin, Bohec, Mylène, Baulande, Sylvain, Dahmani, Ahmed, Sourd, Laura, Letouzé, Eric, Salomon, Anne-Vincent, Marangoni, Elisabetta, Perié, Leïla, Vallot, Céline · 2022 · Nature Genetics
Cited by 178

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The persistence of cancer cells resistant to therapy remains a major clinical challenge. In triple-negative breast cancer, resistance to chemotherapy results in the highest recurrence risk among breast cancer subtypes. The drug-tolerant state seems largely defined by nongenetic features, but the underlying mechanisms are poorly understood. Here, by monitoring epigenomes, transcriptomes and lineages with single-cell resolution, we show that the repressive histone mark H3K27me3 (trimethylation of histone H3 at lysine 27) regulates cell fate at the onset of chemotherapy. We report that a persister expression program is primed with both H3K4me3 (trimethylation of histone H3 at lysine 4) and H3K27me3 in unchallenged cells, with H3K27me3 being the lock to its transcriptional activation. We further demonstrate that depleting H3K27me3 enhances the potential of cancer cells to tolerate chemotherapy. Conversely, preventing H3K27me3 demethylation simultaneously to chemotherapy inhibits the transition to a drug-tolerant state, and delays tumor recurrence in vivo. Our results highlight how chromatin landscapes shape the potential of cancer cells to respond to initial therapy. Single-cell multiomic profiling of triple-negative breast cancer samples treated with capecitabine shows that H3K27me3 regulates a persister cell state. Blocking H3K27me3 demethylation inhibits the transition to a drug-tolerant state and delays tumor recurrence.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-022-01047-6

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 178

Metadata

Authors
Marsolier, J., Prompsy, P., Durand, A., Lyne, A.-M., Landragin, C., Trouchet, A., Bento, S. T., Eisele, A., Foulon, S., Baudre, L., Grosselin, K., Bohec, M., Baulande, S., Dahmani, A., Sourd, L., Letouzé, E., Salomon, A.-V., Marangoni, E., Perié, L., & Vallot, C.
Venue
Nature Genetics
Published
2022-04
Volume
54
Issue
4
Pages
459-468
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W4223525416
Cited by
178
References
20
FWCI
10.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: H3K27me3 conditions chemotolerance in triple-negative breast cancer. https://app.cochat.ai/papers/10.1038/s41588-022-01047-6
The paper
Marsolier, J., Prompsy, P., Durand, A., Lyne, A.-M., Landragin, C., Trouchet, A., Bento, S. T., Eisele, A., Foulon, S., Baudre, L., Grosselin, K., Bohec, M., Baulande, S., Dahmani, A., Sourd, L., Letouzé, E., Salomon, A.-V., Marangoni, E., Perié, L., & Vallot, C. (2022). H3K27me3 conditions chemotolerance in triple-negative breast cancer. Nature Genetics. https://doi.org/10.1038/s41588-022-01047-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.